We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

125 hedge funds and large institutions have $210M invested in Arena Pharmaceuticals Inc in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 44 increasing their positions, 35 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 7

47% more call options, than puts

Call options by funds: $1.37M | Put options by funds: $931K

26% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 35

5% more funds holding

Funds holding: 119 → 125 (+6)

3% more capital invested

Capital invested by funds: $203M → $210M (+$6.69M)

Holders
125
Holders Change
+6
Holders Change %
+5.04%
% of All Funds
3.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
44
Reduced
35
Closed
7
Calls
$1.37M
Puts
$931K
Net Calls
+$436K
Net Calls Change
-$161K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$2.21M
2
BFA
BlackRock Fund Advisors
California
+$766K
3
TC
TFS Capital
Pennsylvania
+$642K
4
Millennium Management
Millennium Management
New York
+$581K
5
State Street
State Street
Massachusetts
+$477K

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.92M
2
SAM
Senzar Asset Management
New York
-$389K
3
Deutsche Bank
Deutsche Bank
Germany
-$247K
4
VKH
Virtu KCG Holdings
New York
-$233K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$178K
Name Holding Trade Value Shares
Change 		Change in
Stake
ARTA
76
A.R.T. Advisors
New York
$46K +$43.9K +2,650 New
Teacher Retirement System of Texas
77
Teacher Retirement System of Texas
Texas
$45K -$13.2K -796 -23%
AWM
78
Affinity Wealth Management
Delaware
$43K +$40.7K +2,454 New
Tudor Investment Corp
79
Tudor Investment Corp
Connecticut
$42K -$3.52K -212 -8%
CSIC
80
Clifford Swan Investment Counsel
California
$41K – – –
BlackRock
81
BlackRock
New York
$40K +$3.47K +209 +10%
ClearBridge Investments
82
ClearBridge Investments
New York
$39K +$37.2K +2,244 New
Simplex Trading
83
Simplex Trading
Illinois
$37K +$3.77K +227 +12%
BRWA
84
B. Riley Wealth Advisors
Florida
$37K +$8.29K +500 +31%
BNP Paribas Financial Markets
85
BNP Paribas Financial Markets
France
$35.3K +$17.8K +1,071 +113%
HighTower Advisors
86
HighTower Advisors
Illinois
$35K – – –
HCM
87
Hollencrest Capital Management
California
$35K +$1.24K +75 +4%
D.E. Shaw & Co
88
D.E. Shaw & Co
New York
$35K +$33.5K +2,020 New
AIP
89
Ameritas Investment Partners
Nebraska
$34K – – –
Canada Life
90
Canada Life
Manitoba, Canada
$34K – – –
Bank of America
91
Bank of America
North Carolina
$30K -$28.3K -1,706 -50%
CC
92
Cedar Capital
Illinois
$29K – – –
TSS
93
Two Sigma Securities
New York
$29K +$10K +605 +59%
N
94
Nuveen
North Carolina
$28K – – –
WS
95
Wedbush Securities
California
$27K +$1.66K +100 +7%
NPC
96
National Planning Corporation
California
$26K -$5.89K -355 -17%
PPA
97
Parametric Portfolio Associates
Washington
$24K -$481 -29 -2%
LPL Financial
98
LPL Financial
California
$22K -$7.55K -455 -27%
PA
99
Profund Advisors
Maryland
$20K +$19.2K +1,156 New
JHIU
100
Janus Henderson Investors US
Colorado
$19K -$2.84K -171 -13%
2 3
4
5 6

ARNA Hedge Fund Activity: Q3 2016 in Review

125 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q3 2016, worth a combined $210M — up 3.3% from $203M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ARNA positions and 7 closed out — a net gain of 7 holders — while 44 added to existing stakes and 35 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $2.21M. The largest seller was Wellington Management Group, cutting an estimated $1.92M.

  • 125 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q3 2016, up from 119 in Q2 2016.
  • Funds reported $210M of Arena Pharmaceuticals Inc stock for Q3 2016, up 3.3% quarter-over-quarter.
  • 14 funds opened new Arena Pharmaceuticals Inc positions in Q3 2016 and 7 closed out, a net change of +7 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q3 2016 was Renaissance Technologies, an estimated $2.21M added.
  • The largest Arena Pharmaceuticals Inc seller in Q3 2016 was Wellington Management Group, an estimated $1.92M sold.

Based on aggregated 13F filings for Q3 2016.